ExoVasc® Personalised External Aortic Root Support

The ExoVasc® Personalised External Aortic Root Support is a revolutionary new device. It is designed to manage aortic dilation in people with Marfan syndrome and related genetic conditions.

The ExoVasc® is placed around the ascending aorta where it provides support to the patient’s own aorta and aortic valve and is designed to prevent enlargement and rupture.

This innovation developed by Exstent Limited sets a new standard in the surgical management of the dilated aorta. More than 140 patients have now received their ExoVasc® support and its effectiveness is proven by a total of over 450 patient-years’ experience gained during the past 14 years.

This site contains more information on the ExoVasc® support and the company behind its development.

: Watch an extract from the BBC2 documentary Incredible Medicine broadcast on 29 March 2017 which featured the ExoVasc® Personalised External Aortic Root Support

Watch and listen to more about PEARS

Latest News...

Exstent appoints distributors in eight countries

As interest in the ExoVasc PEARS device grows around the world, Exstent has appointed distributors in Australia, Belgium, the Czech Republic, France, Italy, the Netherlands, New Zealand and Spain. By partnering with established distributors in these territories the company can form close links with key surgeons and offer this innovative alternative to aortic root replacement to a larger number of patients.

The first PEARS surgery recently completed in the Netherlands was the result of a patient contacting the company. The story has made the national news (see www.rtlnieuws.nl/nederland/hartpatient-introduceert-revolutionaire-operatie-in-nederland and www.amc.nl/web/ons-amc/verhalen/community/patient-introduceert-nieuwe-hartingreep.htm) and Amsterdam surgeon David Koolbergen plans to offer this surgery to further patients in the near future.

Tal Golesworthy speaks at London Cardiothoracic Surgery Core Review Course

Tal Golesworthy spoke at the London Cardiothoracic Surgery Core Review Course which was held 10-13 May 2018 at the Royal Society of Medicine in London, UK.

The London Cardiothoracic Surgery Core Review Course attracts delegates from the UK and worldwide. Tal Golesworthy spoke as part of the UK Supplement, which was aimed at trainees but also a wider audience including consultants.

For more information visit www.corereview.co.uk.